Skip to main content
Top

Clinical and Experimental Nephrology

Issue 4/2024

Content (10 Articles)

Chronic Kidney Disease Original article

Duodenal microbiome in chronic kidney disease

Masahiro Kondo, Takehiro Torisu, Tomohiro Nagasue, Hiroki Shibata, Junji Umeno, Keisuke Kawasaki, Shin Fujioka, Yuichi Matsuno, Tomohiko Moriyama, Takanari Kitazono

Acute Kidney Injury Original article

Single and combination immunotherapy with chemotherapy and the risk of AKI in patients with solid cancer

Germana Alves de Brito, Antonio Paulo Nassar Junior, Milton Barros e Silva, Barbara Beltrame Bettim, Benedito Jorge Pereira

Diabetic Nephropathy Original article

Differential impact of glomerular and tubule-interstitial histological changes on kidney outcome between non-proteinuric and proteinuric diabetic nephropathy

Fumihiro Fukata, Masahiro Eriguchi, Hiroyuki Tamaki, Takayuki Uemura, Hikari Tasaki, Riri Furuyama, Masatoshi Nishimoto, Takaaki Kosugi, Kaori Tanabe, Katsuhiko Morimoto, Keisuke Okamoto, Masaru Matsui, Ken-ichi Samejima, Kazuhiko Tsuruya

Original article

Relationship between the serum creatinine concentrations of preterm neonates within 24 h of birth and their mothers before delivery

Wataru Shimabukuro, Shogo Nakada, Kohei Shimada, Mayumi Tsukayama, Kazuya Hamada, Hideki Goya, Noriko Kinjo, Tomohide Yoshida, Keiko Mekaru, Koichi Nakanishi

Chronic Kidney Disease Original article

Association between the serum zinc level and nutritional status represented by the geriatric nutritional Rrisk index

Makoto Sagasaki, Yukio Maruyama, Akio Nakashima, Akira Fukui, Takashi Yokoo

Open Access Electrocardiography Original article

Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease

Ken Hirabayashi, Hideki Fujii, Keiji Kono, Satoshi Yamatani, Mao Shimizu, Kentaro Watanabe, Kazuo Sakamoto, Shunsuke Goto, Shinichi Nishi

Rituximab Original article

Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis

Mayumi Takahashi-Kobayashi, Ken-Ei Sada, Soko Kawashima, Yoshia Miyawaki, Daigo Nakazawa, Kengo Furuichi, Hirokazu Okada, Ichiei Narita, Joichi Usui

Chronic Kidney Disease Original article

AHA Life’s Essential 8 and new-onset CKD: a prospective cohort study from the UK Biobank

Yong-Xiang Ruan, Mao-Xiong Wu, Jing-Wei Gao, Da-Chuan Guo, Yang-Wei Cai, Ze-Gui Huang, Wan-Bing He, Yang-Xin Chen, Jing-Feng Wang, Hai-Feng Zhang

Open Access Rituximab Original article

Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)

Kandai Nozu, Mayumi Sako, Seiji Tanaka, Yuji Kano, Yoko Ohwada, Tamaki Morohashi, Riku Hamada, Yasufumi Ohtsuka, Masafumi Oka, Koichi Kamei, Aya Inaba, Shuichi Ito, Tomoyuki Sakai, Hiroshi Kaito, Yuko Shima, Kenji Ishikura, Hidefumi Nakamura, Koichi Nakanishi, Tomoko Horinouchi, Akihide Konishi, Takashi Omori, Kazumoto Iijima

Peritoneal Dialysis Original article

Impact of nutrition and inflammation indicators on peritoneal dialysis initiation and management

Shunta Hori, Mitsuru Tomizawa, Kuniaki Inoue, Tatsuo Yoneda, Akira Tachibana, Tatsuki Miyamoto, Kenta Onishi, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine